KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Cash from Investing Activities Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.55%
Dec 31, 2025 12.92%
Sep 30, 2025 23.96%
Jun 30, 2025 29.02%
Mar 31, 2025 -14.21%
Dec 31, 2024 41.69%
Sep 30, 2024 -15.32%
Jun 30, 2024 -15.76%
Mar 31, 2024 -15.56%
Dec 31, 2023 -42.33%
Sep 30, 2023 -17.41%
Jun 30, 2023 -15.68%
Mar 31, 2023 -38.07%
Dec 31, 2022 -113.66%
Sep 30, 2022 32.99%
Jun 30, 2022 -3.88%
Mar 31, 2022 6.70%
Dec 31, 2021 28.40%
Sep 30, 2021 15.22%
Jun 30, 2021 30.88%
Mar 31, 2021 40.81%
Dec 31, 2020 -42.81%
Sep 30, 2020 4.06%
Jun 30, 2020 1.76%
Mar 31, 2020 24.73%
Dec 31, 2019 -78.15%
Sep 30, 2019 30.95%
Jun 30, 2019 25.53%
Mar 31, 2019 46.06%
Dec 31, 2018 14.45%
Sep 30, 2018 20.44%
Jun 30, 2018 8.44%
Mar 31, 2018 52.47%
Dec 31, 2017 47.90%
Sep 30, 2017 9.04%
Jun 30, 2017 5.77%
Mar 31, 2017 41.77%
Dec 31, 2016 -40.91%
Sep 30, 2016 -22.76%
Jun 30, 2016 -22.66%
Mar 31, 2016 -51.23%
Dec 31, 2015 13.85%
Sep 30, 2015 -9.52%
Jun 30, 2015 -10.45%
Mar 31, 2015 0.06%
Dec 31, 2014 25.42%
Sep 30, 2014 -15.36%
Jun 30, 2014 -9.23%
Mar 31, 2014 -49.64%